The global botulinum toxin in urology market is positioned for sustained expansion, driven by rising preference for non-surgical treatment solutions for bladder and pelvic disorders. According to industry insights, the market is expected to grow from USD 1.09 billion in 2025 to USD 1.95 billion by 2035, reflecting a CAGR of 6.0% and expanding close to 1.8 times...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek